Xiaobo Cai
- Hepatology top 5%
- Liver physiology and pathology 16
- Liver Disease and Transplantation 2
-
- Liver Disease Diagnosis and Treatment 9
-
- Phagocytosis and Immune Regulation 3
-
- Endoplasmic Reticulum Stress and Disease 2
- Hippo pathway signaling and YAP/TAZ 2
-
- Pancreatic and Hepatic Oncology Research 3
-
- Genetic factors in colorectal cancer 2
- Cited by
- HepatologyEpidemiologyImmunology
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)The FASEB Journal (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaobo Cai
22 papers receiving 375 citations
Peers
Comparison fields: 5 of 71
- Hepatology 173
- Epidemiology 179
- Immunology 51
- Cell Biology 35
- Cancer Research 30
Countries citing papers authored by Xiaobo Cai
This map shows the geographic impact of Xiaobo Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Cai more than expected).
Fields of papers citing papers by Xiaobo Cai
This network shows the impact of papers produced by Xiaobo Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Cai. The network helps show where Xiaobo Cai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaobo Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 14 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 30 | |
| 14 | 2019 | 51 | |
| 15 | 2019 | 20 | |
| 16 | 2017 | 10 | |
| 17 | 2016 | 36 | |
| 18 | 2016 | 21 | |
| 19 | 2016 | 7 | |
| 20 | 2016 | 10 |
About Xiaobo Cai
Xiaobo Cai is a scholar working on Hepatology, Epidemiology and Cell Biology, having authored 24 papers that have together received 377 indexed citations. Recurring topics across this work include Liver physiology and pathology (16 papers), Liver Disease Diagnosis and Treatment (9 papers), Pancreatic and Hepatic Oncology Research (3 papers), Phagocytosis and Immune Regulation (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Genetic factors in colorectal cancer (2 papers), Liver Disease and Transplantation (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). The work is most often cited by research in Hepatology (173 citations), Epidemiology (179 citations) and Immunology (51 citations). Xiaobo Cai has collaborated with scholars based in China and United States. Frequent co-authors include Mingyi Xu, Qidi Zhang, Ying Qu, Zhenghong Li, Lungen Lu, Xinjian Wan, Lungen Lu, Zhenzeng Ma, Liuying Chen and Tianyi Gu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.